Current clinical landscape of oncolytic viruses as novel cancer immunotherapeutic and recent preclinical advancements

Chae-Ok Yun, JinWoo Hong, A-Rum Yoon

Open source

DOI
10.3389/fimmu.2022.953410
Published
2022-08-25
Container
Frontiers in Immunology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2022.953410,
  title = {Current clinical landscape of oncolytic viruses as novel cancer immunotherapeutic and recent preclinical advancements},
  author = {Chae-Ok Yun and JinWoo Hong and A-Rum Yoon},
  year = {2022},
  journal = {Frontiers in Immunology},
  doi = {10.3389/fimmu.2022.953410},
  url = {https://doi.org/10.3389/fimmu.2022.953410}
}

RIS

TY  - JOUR
TI  - Current clinical landscape of oncolytic viruses as novel cancer immunotherapeutic and recent preclinical advancements
AU  - Chae-Ok Yun
AU  - JinWoo Hong
AU  - A-Rum Yoon
PY  - 2022
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2022.953410
UR  - https://doi.org/10.3389/fimmu.2022.953410
ER  - 

APA

Yun, C., Hong, J., & Yoon, A. (2022). Current clinical landscape of oncolytic viruses as novel cancer immunotherapeutic and recent preclinical advancements. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2022.953410

Source records